Tyrosine kinase inhibitor levels matter in treating chronic GVHD Journal Article

  


Authors: van der Wagen, L.; Janssen, J.; Raijmakers, R.; Petersen, E.; de Witte, M.; de Jong, N.; Bellido, M.; Meijer, E.; Bär, B.; Boelens, J. J.; Huitema, A.; Kuball, J.
Article Title: Tyrosine kinase inhibitor levels matter in treating chronic GVHD
Abstract: We observed a possible concentration effect relationship for nilotinib on resolution of chronic Graft versus Host disease.These data suggest therapeutic drug monitoring might be useful for patients receiving tyrosine kinase inhibitors for chronic GVHD. © 2019, Springer Nature Limited.
Journal Title: Bone Marrow Transplantation
Volume: 54
Issue: 7
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2019-07-01
Start Page: 1141
End Page: 1144
Language: English
DOI: 10.1038/s41409-018-0429-5
PUBMED: 30651587
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060140726&doi=10.1038%2fs41409-018-0429-5&partnerID=40&md5=5b3cf7f7ce64d10156314a97d36c0952
Notes: Letter -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Jaap Jan Boelens
    204 Boelens
Related MSK Work